259 results
Page 4 of 13
8-K
EX-99.2
f376pas ak
24 Mar 20
Other Events
8:32am
8-K
EX-99.1
bieh78b sq06r
24 Mar 20
Other Events
8:32am
424B5
uw41pfn4ylhweo
21 Feb 20
Prospectus supplement for primary offering
7:02am
8-K
EX-10.1
51s bl4y9s32wc5aaan5
20 Feb 20
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-14.1
73zijeekz960bfp
18 Dec 19
Departure of Directors or Certain Officers
4:23pm
8-K
EX-99.1
fnz8d1qotvo87a3wbkz
4 Dec 19
Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number
8:44am
8-K
EX-99.1
r50yl3le38r88mjs6
10 Oct 19
Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility
4:01pm
8-K
EX-99.2
yvp veszlg81c
20 Sep 19
Departure of Directors or Certain Officers
4:02pm
8-K
EX-99.1
850nl9sksvlj
20 Sep 19
Departure of Directors or Certain Officers
4:02pm
8-K
EX-99.2
m5a7od dq
11 Jul 19
Changes in Registrant's Certifying Accountant
4:01pm
8-K
EX-99.1
b0rse8s74ljbc8bal
10 Jul 19
Ampio Appoints Dan Stokely as the Company’s new Chief Financial Officer
4:02pm
8-K
EX-99.1
qnsctpxs6vol02iopfs
19 Jun 19
Ampio Pharmaceuticals Announces Closing of $12 Million Public Offering
4:01pm